Menu

Potassium Nitrate

Also known as: KNO3

A sensitivity-toothpaste active whose evidence depends on the formula, stimulus and duration—not the potassium name alone.

A torn-paper collage of an unbranded toothbrush and a white toothpaste-like ribbon against cream and dark-green paper.
Editorial illustration

Potassium nitrate appears as a desensitizing active in some toothpastes. Evidence for symptom reduction varies by formulation, test stimulus and follow-up. In a toothpaste containing both potassium nitrate and sodium fluoride, the label assigns sensitivity and cavity-prevention roles separately; one ingredient name cannot stand in for the whole formula.1, 3, 4

  • An example current label lists 5% potassium nitrate for hypersensitivity and 0.24% sodium fluoride for anticavity use.1
  • The older Cochrane review found stimulus-based signals but no clear overall conclusion from its small evidence base.2
  • The 2026 network review evaluated two-week outcomes; that time point is not interchangeable with six-to-eight-week results.4, 2

What is Potassium Nitrate?

This guide concerns dental exposure in finished toothpaste, not dietary potassium replacement or swallowed nitrate supplements. The cited U.S. label identifies 5% potassium nitrate with a separate fluoride active. Its presence does not explain every therapeutic claim made about the finished paste.1

Where it comes from

Natural sources

  • A defined potassium salt, not an herbal extract or a synonym for dietary potassium as a whole.

How it's made

The relevant exposure is the specified ingredient within a manufactured dentifrice, not raw chemical powder.

What it does in products

  • Antihypersensitivity active in specified dental formulations

Benefits

Sensitivity relief is plausible, but not uniform

limited evidence

Some comparisons favor potassium-containing pastes; this is not a guarantee for every sensitive tooth or product.3, 4, 2

The 2020 network analysis supported the potassium category for tactile outcomes with moderate certainty, while some favorable results involved combinations. The updated 2026 analysis found the most consistent two-week signals for stannous-fluoride and arginine formulas; other formulations generally had lower-certainty results. Do not attribute a mixture's result to nitrate alone.

Evidence scope and limitations

Potassium nitrate in finished dental products, one U.S. label and sensitivity reviews published in 2006, 2020 and 2026; not dietary nitrate or potassium replacement.

  • Potassium categories can include different salts and combinations; indirect results cannot isolate every 5% potassium-nitrate product.
  • The updated review's principal network comparisons concern two weeks, not lifelong relief or treatment of cavities.
  • The label is one product-specific example, not a recommendation, universal age schedule or claim of FDA approval.

Evidence last checked: 2026-10-23

Side effects & safety

Accidental swallowing of more than the brushing amount (varies)The example label directs users to medical or poison-control help. A dental product is not an oral potassium supplement.

Safety considerations

  • The toothpaste studies are not a comprehensive interaction review and do not establish a safe swallowed-nitrate regimen.
  • Not for: Persistent or worsening sensitivity may reflect another dental problem; do not use a toothpaste response to diagnose the cause.
  • Not for: The example label requires professional advice for children under 12 and advises against use beyond four weeks without a dentist or physician's recommendation.
1, 2

Amounts studied & product use

These figures describe research or common product use, not a personal dose or treatment recommendation.

In sensitivity toothpaste

The cited U.S. dental label uses 5% potassium nitrate, alongside 0.24% sodium fluoride. This is finished-product context, not a home-mixing instruction. Follow the specific product's directions, do not swallow it, and do not translate the concentration into a supplement dose.

1

Regulatory status

  • DailyMed hosts the cited U.S. OTC label with separate antihypersensitivity and anticavity purposes; a listing is not by itself proof of product approval. Under FDA's intended-use framework, therapeutic toothpaste claims are not simply cosmetic claims.
1, 5

Why a cold test and a pain diary may disagree

Cochrane's 2006 review found improvements with air-blast and tactile tests at six to eight weeks, but not a significant subjective-assessment benefit. The finding illustrates outcome dependence rather than proving that all sensitivity complaints respond alike.

The newer network reviews compare ingredient categories, controls and sometimes combination formulas. Their results should be read against that design: an indirect category comparison does not guarantee that a different paste will help a particular cause of pain.

2, 3, 4

Frequently asked questions

Does potassium nitrate supply the fluoride benefit too?

No. The example label assigns potassium nitrate to hypersensitivity and sodium fluoride to anticavity use. Check both actives rather than assuming a sensitivity claim establishes cavity prevention.1

The bottom line

Match the complete toothpaste and the type of outcome to the evidence; ongoing pain still needs a dental explanation.

References

  1. Sensitive Teeth and Gums: potassium nitrate, sodium fluoride dentifrice label. Church & Dwight Co., Inc. / DailyMed (2026) · ingredient monograph · SPL set ID 935172db-d78f-0c69-e053-2a95a90a0b69, version 6; updated July 23, 2026; product-specific label, not an endorsement or proof of FDA product approval
  2. Poulsen S, Errboe M, Lescay Mevil Y, Glenny AM. Potassium containing toothpastes for dentine hypersensitivity. Cochrane Database of Systematic Reviews (2006) · systematic review · CD001476; DOI 10.1002/14651858.CD001476.pub2; published July 19, 2006; historical review, not the latest evidence
  3. Martins CC, Firmino RT, Riva JJ, et al.. Desensitizing Toothpastes for Dentin Hypersensitivity: A Network Meta-analysis. Journal of Dental Research (2020) · meta analysis · PMID 32037944; DOI 10.1177/0022034520903036; primary abstract checked; potassium categories and combination formulations distinguished
  4. Gormley AJ, Walsh T, Twigg J, et al.. Dentifrice formulations for the treatment of dentin hypersensitivity: A systematic review and network meta-analysis. Periodontology 2000 (2026) · meta analysis · DOI 10.1111/prd.70088; first published August 31, 2026; primary abstract and two-week outcome scope checked
  5. Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?). U.S. Food and Drug Administration · government guidance · Undated agency resource; intended-use and toothpaste cosmetic/drug distinctions checked October 23, 2026

Revision history

  1. Initial AI-assisted source compilation with claim-level citations, formulation distinctions and explicit evidence limitations; not independent medical review.